TD Cowen Maintains Rallybio(RLYB.US) With Buy Rating
H.C. Wainwright Maintains Rallybio(RLYB.US) With Buy Rating, Maintains Target Price $5
Promising Pipeline and Upcoming Catalysts Drive Buy Rating for Rallybio
JMP Securities Maintains Rallybio(RLYB.US) With Buy Rating, Maintains Target Price $7
JMP Securities Maintains Rallybio(RLYB.US) With Buy Rating, Maintains Target Price $7
JMP Securities Maintains Rallybio(RLYB.US) With Buy Rating, Maintains Target Price $7
H.C. Wainwright Maintains Rallybio(RLYB.US) With Buy Rating, Maintains Target Price $5
Rallybio Analyst Ratings
Rallybio's RLYB116: Promising Developments and Buy Rating Driven by Enhanced Manufacturing and Potential in Phase 1 Trials
H.C. Wainwright Maintains Rallybio(RLYB.US) With Buy Rating, Maintains Target Price $5
Rallybio Analyst Ratings
TD Cowen Maintains Rallybio(RLYB.US) With Buy Rating
H.C. Wainwright Maintains Rallybio(RLYB.US) With Buy Rating, Cuts Target Price to $5
TD Cowen Maintains Rallybio(RLYB.US) With Buy Rating
TD Cowen Maintains Rallybio(RLYB.US) With Buy Rating
Rallybio Analyst Ratings
H.C. Wainwright Maintains Rallybio(RLYB.US) With Buy Rating, Maintains Target Price $6
H.C. Wainwright Maintains Rallybio(RLYB.US) With Buy Rating, Maintains Target Price $6
HC Wainwright & Co. Reiterates Buy on Rallybio, Maintains $6 Price Target
Rallybio Analyst Ratings